NBC Securities’s Acurx Pharmaceuticals ACXP Stock Holding History

NBC Securities’s Portfolio ACXP Stock Details ACXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.57K	Hold	1,500	–	–	﹤0.01%	2088
2025 Q4	$3.73K	Hold	1,500	–	–	﹤0.01%	2276
2025 Q3	$6.43K	Hold	1,500	–	–	﹤0.01%	2129
2025 Q2	$15K	Hold	1,500	–	–	﹤0.01%	1813
2025 Q1	$11K	Buy	1,500 +1,499	+149,900%	+$20.2K	﹤0.01%	1692
2024 Q4	$15	Sell	1 -949	-100%	-$28.6K	﹤0.01%	1168
2024 Q3	$36K	Hold	950	–	–	﹤0.01%	1276
2024 Q2	$42K	Buy	950 +250	+36%	+$11K	﹤0.01%	1188
2024 Q1	$34K	Buy	+700	New	+$45.5K	﹤0.01%	1244

Other funds holding ACXP

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

PFS

Prospect Financial Services Melville, New York $164M AUM 19.24% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

NBC Securities's ACXP Position: Q1 2026 in Review

NBC Securities held its Acurx Pharmaceuticals (ACXP) position steady in Q1 2026 at 1,500 shares worth $5.57K. The position accounts for ﹤0.01% of the portfolio, ranked #2088.

NBC Securities first reported a position in ACXP in Q1 2024 and has held it in 9 quarters since. The position peaked at $42K in Q2 2024. 21 funds tracked by Wall St. Rank hold ACXP as of Q1 2026.

NBC Securities held 1,500 shares of Acurx Pharmaceuticals worth $5.57K as of Q1 2026.
NBC Securities left its Acurx Pharmaceuticals share count unchanged in Q1 2026.
Acurx Pharmaceuticals made up ﹤0.01% of NBC Securities's portfolio in Q1 2026, its #2088 holding.
NBC Securities first reported a position in Acurx Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
NBC Securities's Acurx Pharmaceuticals position peaked at $42K in Q2 2024.
21 funds tracked by Wall St. Rank held Acurx Pharmaceuticals as of Q1 2026.

Based on NBC Securities's 13F filing for Q1 2026, filed 14 Apr 2026.